VANCOUVER, BC , Jan. 28, 2021 /CNW/ - Pontus Protein Ltd . (" Pontus " or the " Company ") (TSXV: HULK), is pleased to announce that its common shares will commence trading on the TSX Venture Exchange (" TSXV ") on January 28, 2021 under the symbol "HULK".
"This is a pivotal moment for Pontus as we are now listed on the TSXV and this is the next step in our growth to capitalize on the increase in global demand for plant based and alternative proteins," said Connor Yuen, Chief Executive Officer of Pontus. "We believe the listing of our common shares in the public markets will increase awareness, interest and growth of Pontus and our Pontus Protein Powder and will enable the Company to further develop and meet the demands of global demand."
About Pontus
Pontus was founded in 2018 and is a British Columbia -based agri-tech company whose primary objective is to deliver new sources of organic plant-based protein products. Pontus specializes in aquaponic farming through the employment of its proprietary Closed Environment Vertical Aquaponics System™ or CEVAS™ system, a network of automated bio-secure indoor aquaponic farms utilizing AI, to produce a sustainable, non-GMO, organic plant-based protein product called Pontus Protein Powder. Pontus Protein Powder is a 42.1% pure plant protein produced from water lentils, high in antioxidants, essential vitamins and minerals, grown without solvents, chemicals, and dyes additives, preservatives or pesticides.
Pontus is currently completing the construction and outfitting of a 20,570 sq/ft processing farm located in Surrey, British Columbia (the " Surrey Farm "). Pontus' Surrey Farm will utilize the proprietary CEVAS™ technology and equipment at scale for the production of Pontus Protein Powder. For more information, please visit https://pontuswaterlentils.com/ .
On behalf of the Board of Directors
"Connor Yuen"
Connor Yuen , CEO
Pontus Protein Ltd.
Contact Information
For more information, please contact:
Connor Yuen
Chief Executive Officer
(778) 999-3353
For media enquiries or interviews, please contact:
Victoria Bennett
victoria@bmwconsults.com
(403) 589-7992
https://drive.google.com/drive/folders/1KB7brJRPOLGQ4iIbw8VIYWX_zKQrDYS3?usp=sharing
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to the trading of the common shares on the TSXV and any additional benefits the listing may have on awareness Pontus, its Pontus Protein Power or ability to meet the market demands of the plant based and alternative protein market. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the unknown business effects of the listing of Pontus' common shares on the facilities of the TSXV, and other general business, economic, or market related risks. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.
This press release is not an offer of the securities for sale in the United States . The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Pontus Protein Ltd.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2021/28/c1032.html